
Individualized, evidence-based care in a private Hollywood Hills setting. Same clinical team from intake through aftercare.

Bipolar disorder and substance use disorders are among the most commonly co-occurring conditions in clinical practice. Each condition tends to worsen the other — substances are frequently used to manage bipolar symptoms, while sustained substance use worsens the underlying condition and makes recovery harder. Bipolar disorder frequently co-occurs with major depression and anxiety disorders — conditions that can be difficult to distinguish from bipolar mood episodes without careful clinical assessment.
Treating only the addiction without addressing bipolar disorder leaves the most powerful driver of substance use unaddressed. This is why integrated dual diagnosis treatment — treating both conditions simultaneously within a unified clinical plan — produces significantly better outcomes than treating either in isolation.
Bipolar disorder presents alongside addiction in ways that can make diagnosis and treatment more complex. Substance use can mimic, mask, or worsen bipolar disorder symptoms. A comprehensive clinical assessment — conducted after a sufficient period of stabilization — is essential for accurate diagnosis and appropriate treatment planning.
Substance use significantly complicates the diagnosis and management of bipolar disorder. Some substances produce mood states that look exactly like bipolar episodes.
Our admissions team is available around the clock — confidentially, and without pressure.
Careful medication management with mood stabilizers and atypical antipsychotics selected to avoid interactions with substances of abuse.
Daily clinical observation tracks mood shifts, sleep patterns, and energy levels to catch early warning signs before they escalate.
Structured plans that address both manic impulsivity and depressive withdrawal, with triggers mapped for both conditions.
"Mood stability and sobriety are inseparable goals. You cannot achieve one without addressing the other."

Careful medication management with mood stabilizers and atypical antipsychotics — selected to avoid interactions with substances of abuse — forms the clinical foundation of bipolar and addiction treatment. Daily observation tracks mood shifts from day one.

CBT and structured relapse prevention planning address both manic impulsivity and depressive withdrawal. Triggers for both mood episodes and substance use are mapped and addressed within the same clinical framework.

Mood stability and sobriety are inseparable goals. Our unified clinical plan treats bipolar disorder and substance use disorder simultaneously — because treating only one leaves the other unaddressed and relapse risk high.

Recovery extends beyond discharge. Our step-down PHP/IOP programming and alumni community keep clients connected, accountable, and supported during the months and years that follow residential treatment.

You don't have to face bipolar disorder and addiction alone. Our team of compassionate clinicians is available around the clock — confidentially, and without pressure — to guide you toward lasting recovery.
Substances can produce mood states that look exactly like bipolar episodes. A period of sobriety — typically 4–8 weeks — is generally needed before bipolar disorder can be diagnosed with confidence.
Often yes. Mood stabilizers and atypical antipsychotics need to be selected with awareness of addiction history and interaction effects with substances.
People with bipolar disorder have some of the highest rates of co-occurring substance use of any psychiatric diagnosis. During depressive episodes, substances may be used to manage low mood, fatigue, and hopelessness. During hypomanic or manic episodes, impulsivity and reduced inhibition increase risky substance use. Alcohol, stimulants, and sedatives can all temporarily alter mood in ways that feel self-regulatory — but worsen mood cycling over time.
Yes. We're in-network with HealthSmart, MultiPlan, PMCS, and TriWest, and most major commercial PPO plans cover integrated dual-diagnosis treatment for bipolar disorder and co-occurring substance use disorder under the Mental Health Parity and Addiction Equity Act. Coverage depends on your specific plan and level of care. Our admissions team verifies your benefits in detail before you commit to anything.
Most clients begin with medically supervised detox (5 to 10 days), followed by residential treatment of an individualized length. Mood stabilization for bipolar disorder — finding the right medication regimen, titrating doses, and allowing adequate time for the drug to reach therapeutic effect — often requires a longer residential stay than addiction treatment alone. PHP and IOP step-down programming typically add another 4 to 12 weeks.
Treatment begins with a comprehensive psychiatric assessment — often including a period of sobriety to distinguish substance-induced mood episodes from primary bipolar disorder. Our clinical team builds a unified plan addressing mood stabilization and addiction recovery simultaneously. Psychiatric medication management runs alongside evidence-based therapy (CBT for bipolar, DBT for emotional regulation) and holistic modalities.
For clients with active bipolar symptoms and concurrent substance use, residential treatment provides the most stable environment for stabilization: 24/7 psychiatric access, consistent clinical monitoring of mood state, medication adjustment as needed, and removal from the environmental triggers that drive both substance use and mood episodes. PHP and IOP are appropriate next steps after the client is stabilized.
Co-occurring disorders reinforce each other. We treat both simultaneously — with psychiatric support, therapy, and medication management.